☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC October Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Sitagliptin (Januvia®) has been accepted for restricted use in patients with type 2 diabetes. It is recommended that this agent is used in patients where diet and exercise combined with metformin does not provide adequate glycaemic control and sulphonylureas are contraindicated or not tolerated. They should be considered an alternative to glitazones.

Escitalopram (Cipralex®) has been rejected for the treatment of obsessive compulsive disorder. The economic data submitted was not sufficiently robust to gain acceptance.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Share 'SMC October Update' by emailShare 'SMC October Update' on FacebookShare 'SMC October Update' on TwitterShare 'SMC October Update' on LinkedInShare 'SMC October Update' on reddit


No Comments to “SMC October Update”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.